Blog

Aug 2, 2024, 01:47

Sergio Cifuentes Canaval: Neoadjuvant Chemo-Immuno for ER+ HER- breast cancer

Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent paper by Alejandro Ríos-Hoyo et al., titled “Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer” published on Journal of Clinical Oncology.

Authors: Alejandro Ríos-Hoyo, Erin Cobain, Laura A. Huppert, Peter D. Beitsch, Thomas A. Buchholz, Laura Esserman, Laura J. van ‘t Veer, Hope S. Rugo, Lajos Pusztai.

“Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer
– Congratulations to Alejandro Ríos-Hoyo.”

Source: Sergio Cifuentes Canaval/LinkedIn

Alejandro Ríos-Hoyo Breast Cancer cancer Erin Cobain Estrogen Receptor–Positive Human Epidermal Growth Factor 2 Hope S. Rugo Journal of Clinical Oncology Lajos Pusztai Laura A. Huppert Laura Esserman Laura J. van ‘t Veer OncoDaily Oncology Peter D. Beitsch Sergio Cifuentes Canaval Thomas A. Buchholz

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage